Lv21
160 积分 2025-09-21 加入
Sonrotoclax: First Approval
10小时前
待确认
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs
11小时前
已完结
BCL-2 and BTK inhibitors for chronic lymphocytic leukemia: current treatments and overcoming resistance
2个月前
已完结
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
3个月前
已完结
Venetoclax in the treatment of chronic lymphocytic leukemia
3个月前
已完结
Management of Relapsed and/or Refractory Chronic Lymphocytic Leukemia
3个月前
已关闭
Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review
3个月前
已完结
Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study
5个月前
已完结
Golidocitinib: First Approval
6个月前
已完结
Phase I dose escalation and expansion study of golidocitinib, a highly selective JAK1 inhibitor, in relapsed or refractory peripheral T-cell lymphomas
6个月前
已完结
皖公网安备34019202002308
